This Week’s Medical Device News From Nano Gold To FDA Regulatory Fairydust

Whether you’re Synthes, J&J, Boston Scientific or especially Cameron Health, it’s been a pretty good week. Now all we need to do is see a resolution to the endless regulatory debates both sides of the pond and we’ll be happy. Won’t we? Did somebody say 2.3% device tax?

Like an episode of Dallas this week’s Medical Device news is an eclectic mix of intrigue, corporate machinations, money and breakthroughs. Unlike an episode of Dallas there are lots of new products and approvals and a fair dose of regulatory banter. It’s all here in our sidelong glance at the week just passed.

published: April 27, 2012 in: medlatest Editorial, Regulatory

Most read

Latest

^